How family physicians can bridge the care gap for cancer survivors
By Kathleen N. Mueller, MD, FAAFP
The transition from active cancer treatment to survivorship is often celebrated as a finish line. However, for many patients, it marks the beginning of a complex, silent phase of recovery. As oncology teams step back, family physicians step into a critical role. With more than 18 million cancer survivors in the United States, family physicians and other primary care clinicians are increasingly managing the long-term impacts of cancer treatment.
Caring for patients who have survived cancer goes far beyond monitoring them for recurrence. It also requires proactive, systematic symptom management to restore their quality of life. Four chronic, often under-reported issues demand our attention in the clinic: lymphedema, chronic pain, cancer-related fatigue and chemotherapy-induced peripheral neuropathy.
AAFP resources on lymphedema care and cancer survivorship in primary care can help us and our patients navigate these challenges.
Lymphedema: Early detection and intervention
Lymphedema is a dreaded and potentially progressive complication resulting from lymph node dissection, radiation or tumor clearance. Though most commonly associated with breast cancer, it also frequently affects survivors of gynecologic, urologic, and head and neck malignancies.
The clinical hurdle: Patients often dismiss early swelling as a normal post-surgical change, delaying evaluation until tissue fibrosis occurs.
Short-term action: Integrate limb measurements or subjective symptom checks, such as feelings of heaviness, tightness or different clothing fit, into routine exams.
Management: Management is centered on complex decongestive therapy, which includes manual lymphatic drainage, compression garments, meticulous skin care to prevent cellulitis and specialized exercise. Early referral to a certified lymphedema therapist can halt progression and prevent irreversible structural changes. Certified specialists are usually physical or occupational therapists with targeted training for treatment of this population. These experts can help measure and recommend lymphedema garments or devices for individualized treatment.
Chronic pain: Navigating complex disease processes
Cancer survivors experience a wide array of issues related to pain. Post-radiation fibrosis, surgical scar tissue, persistent bone pain from endocrine therapies such as aromatase inhibitors, and stress-related and post-surgical muscle spasm all contribute to a complex clinical picture.
The clinical hurdle: Distinguishing benign post-treatment pain from a secondary malignancy or disease recurrence can cause significant diagnostic anxiety for both the physician and patient. Furthermore, managing long-term pain in the wake of the opioid crisis requires careful balancing.
Short-term action: Conduct a thorough multimodal assessment to classify the pain as nociceptive or neuropathic.
Management: Use a tiered, multimodal approach. Non-opioid medications (such as NSAIDs or acetaminophen) and adjuvant medications (such as SNRIs or gabapentinoids) should be paired with non-pharmacological interventions. There is strong evidence that physical therapy, acupuncture, massage therapy and cognitive behavioral therapy reduce cancer-related pain while supporting the patient's autonomy. Some massage therapists have additional certification in oncology massage and are ideal community partners for our patients.
Cancer-related fatigue: Addressing the most common symptom
Cancer-related fatigue is distinct from ordinary tiredness; it is a persistent, overwhelming exhaustion unrelated to recent activity that is not fully relieved by rest. It can endure for months or even years after cardiotoxic or neurotoxic therapies end.
The clinical hurdle: Because fatigue is subjective and multifaceted, patients often stop mentioning it, assuming nothing can be done.
Short-term action: Rule out secondary, treatable medical drivers of fatigue, including profound anemia, hypothyroidism, cardiac dysfunction, sleep apnea and clinical depression.
Management: Paradoxically, the most robust, evidence-based intervention for cancer-related fatigue is tailored physical activity. Advise survivors to engage in moderate-intensity aerobic exercise, such as 150 minutes of brisk walking each week, alongside resistance training. Your local YMCA may participate in the Live Strong Program, specifically designed to make the post-cancer treatment journey easier. When fatigue is compounded by sleep disturbances or distress, referral for cognitive behavioral therapy for insomnia provides measurable relief. Massage therapy and acupuncture are also being studied for treatment of cancer-related fatigue and may be good options.
Chemotherapy-induced peripheral neuropathy
Prevalent among patients treated with taxanes, platinum agents and vinca alkaloids, CIPN manifests as a symmetrical, “stocking-glove” distribution of numbness, tingling, burning or neuropathic pain.
The clinical hurdle: CIPN not only diminishes quality of life but also introduces significant safety hazards, notably an elevated risk of falls due to impaired proprioception, and a decreased ability to perform daily living activities such as buttoning and handling implements. CIPN may also be associated with intermittent, lancinating pain or persistent tingling.
Short-term action: Ask about changes in sensation during annual wellness visits. Assess home safety and stability.
Management: Duloxetine is the only pharmacotherapy recommended with strong clinical evidence for treating established painful CIPN. Movement helps diminish CIPN symptoms, and there is growing evidence that acupuncture and massage therapy are effective treatment. For patients experiencing gait instability, physical therapy and explicit instructions on podiatric self-care are vital to prevent unperceived trauma and ulceration.
The power of the survivorship care plan
To seamlessly execute this comprehensive care, family physicians should ask the treating oncology team for a survivorship care plan. It serves as a clinical roadmap, explicitly detailing:
The exact regimen, cumulative doses, radiation fields received and clinicians involved.
The recommended schedule for recurrence surveillance.
Potential long-term toxicities specific to the patient's treatment.
The American College of Surgeons Commission on Cancer requires accredited cancer programs to “…offer a formal survivorship program, led by an executive-level lead, that provides comprehensive services for patients who have completed their first course of treatment with curative intent.” Because of these standards of care, most cancer centers now have clinicians with dedicated roles in providing this care. Reach out to your local oncology program to connect with these professionals.
As family physicians, our long-term relationships with patients make us uniquely positioned to handle the aftermath of a cancer diagnosis. By recognizing and addressing the side effects of lymphedema, pain, fatigue and neuropathy, we can shift a patient’s experience from merely surviving to truly thriving.
Kathleen N. Mueller, MD, FAAFP, is a member of the AAFP Board of directors. She serves as the system director for integrative medicine and cancer survivorship for Nuvance, a seven-hospital health system in Connecticut and southeastern New York. She is also the lead editor of Core Content Review of Family Medicine, a medical education program written by and for family physicians.
Disclaimer
The opinions and views expressed here are those of the authors and do not necessarily represent or reflect the opinions and views of the American Academy of Family Physicians. This blog is not intended to provide medical, financial, or legal advice.